Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: An Egyptian study

Renal Failure

Volumn 34, Issue 6, 2012, Pages 670-675

  Bessa, Sahar Saad El Din ^a   Hussein, Tarek Ahmed ^a   Morad, Morad Ahmed ^a   Amer, Amina Mohammed ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

albuminuria; diabetic nephropathy; early detection; platelet derived growth factor BB; type 2 diabetes

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DETERIORATION; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; EARLY DIAGNOSIS; EGYPT; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LABORATORY TEST; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; URINE LEVEL;

ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EGYPT; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-SIS; REGRESSION ANALYSIS;

EID: 84862227127     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.674438     Document Type: Article

References (41)

1. Molnar M, Wittmann I, Nagy J. Prevalence, course and risk factors of diabetic nephropathy in type 2 diabetes mellitus. Med Sci Monit. 2000;6:929-936.
2. Schmitz A, Gundersen HJ, Osterby R. Glomerular morphology by light microscopy in non-insulin dependent diabetes mellitus. Diabetes. 1988;37:38-43. (Pubitemid 18036455)
3. Schrijvers BF, De Vriese A, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine Rev. 2004;25:971-1010. (Pubitemid 39657775)
4. Chiarelli F, Gaspari S, Marcovecchio ML. Role of growth factors in diabetic kidney disease. Horm Metab Res. 2009;41:585-593.
5. Wolf G, Ziyadeh FN. Transforming growth factor-β and diabetic nephropathy. J Organ Dysfunction. 2009;5:130-139.
6. Tam FWK, Riser BL, Meeran K, Rambow J, Pusey CD, Frankel AH. Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokine. 2009; 47:37-42.
7. Ziyadeh FN. Different roles for TGF-? and VEGF in the patho-genesis of the cardinal features of diabetic nephropathy. Diabetes Res Clin Pract. 2008;82:S38-S41.
8. Ross R. Platelet-derived growth factor. Lancet. 1989;1:1179-1182. (Pubitemid 19138858)
9. Heldin CH, Westermark B. Platelet-derived growth factor: Mechanism of action and possible in vivo function. Cell Regul. 1990;1:555-566.
10. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell. 1986;46:155-169. (Pubitemid 16031684)
11. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276-1312. (Pubitemid 351717519)
12. Claesson-Welsh L. Platelet-derived growth factor receptor signals. J Biol Chem. 1994;269:32023-32026.
13. Gilbertson DG, Duff ME, West JW, et al. Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor. J Biol Chem. 2001;276:27406-27414.
14. Changsirikulchai S, Hudkins KL, Goodpaster TA, et al. Platelet-derived growth factor-D expression in developing and mature human kidneys. Kidney Int. 2002;62:2043-2054. (Pubitemid 35366158)
15. Floege J, Eitner F, van Roeyen C, Ostendorf T. PDGF-D and renal disease: Yet another one of those growth factors? J Am Soc Nephrol. 2003;14:2690-2691. (Pubitemid 37169360)
16. Floege J, Eng E, Young BA, et al. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest. 1993;92:2952-2962. (Pubitemid 24006566)
17. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol. 2008;19:12-23.
18. Mauviel A. Transforming growth factor-beta: A key mediator of fibrosis. Methods Mol Med. 2005;117:69-80.
19. Ziyadeh FN. Mediators of diabetic renal disease: The case for TGF-? as the major mediator. J AmSoc Nephrol. 2004;15(Suppl. 1):S55-S57. (Pubitemid 38018457)
20. Langham RG, Kelly DJ, Maguire J, Dowling JP, Gilbert RE, Thomson NM. Over-expression of platelet-derived growth factor in human diabetic nephropathy. Nephrol Dial Transplant. 2003;18:1392-1396. (Pubitemid 36826963)
21. Uehara G, Suzuki D, Toyoda M, Umezono T, Sakai H. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-α, -β in human diabetic nephropathy. Clin Exp Nephrol. 2004;8:36-42. (Pubitemid 38508653)
22. Spooren PF, Lekker JF, Vermes I. Micral test: A qualitative dipstick test for microalbuminuria. Diabetes Res Clin Pract. 1992;18:83-87.
23. Teppo AM. Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin Chem. 1982;28:1359-1361. (Pubitemid 12125075)
24. Maquart FX, Gillery P, Bernard JF, Mante JP, Borel JP. A method for specifically measuring hemoglobin A1c with a disposable commercial ion-exchange column. Clin Chim Acta. 1980;108:329-332. (Pubitemid 11243039)
25. Harrison AA, Dunbar PR, Neale TJ. Immunoassay of platelet-derived growth factor in the blood of patients with diabetes mellitus. Diabetologia. 1994;37:1142-1146. (Pubitemid 24325558)
26. Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes. 1989;38:1077-1081. (Pubitemid 19250390)
27. Frampton G, Hildreth G, Hartley B, Cameron JS, Heldin CH, Wasteson A. Could platelet-derived growth factor have a role in the pathogenesis of lupus nephritis? Lancet. 1988;2:343.
28. Naito T, Nitta K, Ozu H, et al. Clinical assessment of the significance of platelet-derived growth factor in patients with immunoglobulin A nephropathy. J LabClinMed. 1997;130:63-68. (Pubitemid 27340789)
29. Liu G, Changsirikulchai S, Hudkins KL, et al. Identification of platelet-derived growth factor D in human chronic allograft nephropathy. Hum Pathol. 2008;39:393-402.
30. Gesualdo L, Pinzani M, Floriano JJ, et al. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest. 1991;65:160-167.
31. Wang Q, Guan Q, Chen F. The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy. Diabetes Res Clin Pract. 2009;85:166-170.
32. Fagerudd JA, Groop PH, Honkanen E, Teppo AM, Gronhagen-Riska C. Urinary excretion of TGF-?1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. Kidney Int. 1997;52(Suppl. 63):S195-S197. (Pubitemid 28020469)
33. Lev-Ran A, Hwang DL. Epidermal growth factor and platelet-derived growth factor in blood in diabetes mellitus. Acta Endocrinol (Copenh). 1990;123:326-330. (Pubitemid 20340322)
34. Guillausseau PJ, Dupuy E, Bryckaert MC, et al. Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus. Eur J Clin Invest. 1989;19:172-175. (Pubitemid 19102096)
35. Nakagawa H, Sasahara M, Haneda M, Koya D, Hazama F, Kikkawa R. Immunohistochemical characterization of glomerular PDGF-B chain and PDGF-beta receptor expression in diabetic rats. Diabetes Res Clin Pract. 2000;48:87-98. (Pubitemid 30232798)
36. Inaba T, Ishibashi S, Gotoda T, et al. Enhanced expression of platelet-derived growth factor-beta receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes. 1996;45:507-512. (Pubitemid 26110258)
37. Nishida Y, Oda H, Yorioka N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int. 1999;54(Suppl. 71):S51-S53. (Pubitemid 29304813)
38. Tang WW, Ulich TR, Lacey DL, et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol. 1996;148:1169-1180. (Pubitemid 26108254)
39. Wang SN, Hirschberg R. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis. Am J Physiol Renal Electrolyte Physiol. 2000;278:554-560.
40. Fraser D, Wakefield L, Phillips A. Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. Am J Pathol. 2002;161:1039-1049. (Pubitemid 34988392)
41. Vieitez P, Gomez O, Uceda ER, Vera ME, Molina-Holqado E. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. J Renin Angiotensin Aldosterone Syst. 2008;9:96-102. (Pubitemid 351998217)